BREAKING
Home » Posts Tagged "HCV"

Hepatitis C treatment: Mavyret approved as first eight-week treatment

By

The U.S. Food and Drug Administration today expanded the approval of Mavyret (glecaprevir and pibrentasvir) tablets for an eight-week duration for the treatment of adults and children ages 12 years and...

Hepatitis C drug, Mavyret, approved to treat children

By

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) tablets to treat all six genotypes of hepatitis C virus (HCV) in children ages 12 to 17. Mavyret was previously...

Hepatitis C in the US: Nine states account for half of all cases

By

Hepatitis C is a virus (HCV) which can cause serious liver disease. In the early stage of infection, some people will have symptoms of illness including fever, nausea, abdominal pain, or jaundice; however,...

Hepatitis C: Three new strains found in Africa

By

A new study from the Wellcome Sanger Institute, the MRC-University of Glasgow Centre for Virus Research and collaborators and published in the Journal Hepatology of the discovery of three new hepatitis...

Hepatitis: Many European countries not ready to stop public health threat–Study

By

Many European countries lack a comprehensive policy to eliminate viral hepatitis as a major public health threat, according to a patient group-based survey implemented in 25 countries. The Hep-CORE study...

New Hepatitis C combination treatment: High cure rate, Affordable

By

An affordable hepatitis C combination treatment including the new drug candidate ravidasvir has been shown to be safe and effective, with extremely high cure rates for patients, including hard-to-treat...

Study: Screening all adults for Hepatitis C is cost-effective and improves outcomes

By

According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using...

Hepatitis C: New Canadian guidelines recommend against screening low-risk adults

By

The Canadian Task Force on Preventive Health Care recommends against screening for chronic hepatitis C virus (HCV) in adults at low risk in a guideline published in CMAJ (Canadian Medical Association Journal). “Given...

Hep C drugs, Harvoni and Sovaldi, approved for children

By

The U.S. Food and Drug Administration today approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus (HCV) in children ages 12 to 17....

Hepatitis C mutations ‘outrun’ immune systems, lab study shows

By

Unlike its viral cousins hepatitis A and B, hepatitis C virus (HCV) has eluded the development of a vaccine and infected more than 170 million people worldwide. Now, researchers at Johns Hopkins Medicine...